BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6136092)

  • 1. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.
    Nemeroff CB; Youngblood WW; Manberg PJ; Prange AJ; Kizer JS
    Science; 1983 Sep; 221(4614):972-5. PubMed ID: 6136092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptides in CSF and post-mortem brain tissue of normal controls, schizophrenics and Huntington's choreics.
    Manberg PJ; Nemeroff CB; Bissette G; Widerlov E; Youngblood WW; Kizer JS; Prange AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):97-108. PubMed ID: 2859637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced density of striatal somatostatin receptors in Huntington's chorea.
    Palacios JM; Rigo M; Chinaglia G; Probst A
    Brain Res; 1990 Jul; 522(2):342-6. PubMed ID: 1977497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human brain distribution of neurotensin in normals, schizophrenics, and Huntington's choreics.
    Manberg PJ; Nemeroff CB; Iversen LL; Rosser MN; Kizer JS; Prange AJ
    Ann N Y Acad Sci; 1982; 400():354-67. PubMed ID: 6220630
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study.
    Zech M; Roberts GW; Bogerts B; Crow TJ; Polak JM
    Acta Neuropathol; 1986; 71(3-4):259-66. PubMed ID: 2948368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression.
    Biggins JA; Perry EK; McDermott JR; Smith AI; Perry RH; Edwardson JA
    J Neurol Sci; 1983 Jan; 58(1):117-22. PubMed ID: 6405015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia.
    Palacios JM; Chinaglia G; Rigo M; Ulrich J; Probst A
    Synapse; 1991 Feb; 7(2):114-22. PubMed ID: 1672780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease.
    De Souza EB; Whitehouse PJ; Folstein SE; Price DL; Vale WW
    Brain Res; 1987 Dec; 437(2):355-9. PubMed ID: 2893655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue.
    Spokes EG
    Brain; 1980 Mar; 103(1):179-210. PubMed ID: 6102490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
    Constantinidis J; Bouras C; Richard J
    Clin Neuropathol; 1983; 2(2):47-54. PubMed ID: 6189657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptides in Alzheimer's disease: a postmortem study.
    Nemeroff CB; Kizer JS; Reynolds GP; Bissette G
    Regul Pept; 1989 Apr; 25(1):123-30. PubMed ID: 2566190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease.
    Beal MF; Mazurek MF; Ellison DW; Swartz KJ; McGarvey U; Bird ED; Martin JB
    Ann Neurol; 1988 Jun; 23(6):562-9. PubMed ID: 2900622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible pathogenesis of Huntington's chorea and a new approach to treatment.
    Divac I
    Acta Neurol Scand; 1977 Oct; 56(4):357-60. PubMed ID: 21507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of neuropeptides in neurological diseases.
    Sagar SM; Beal MF; Marshall PE; Landis DM; Martin JB
    Peptides; 1984; 5 Suppl 1():255-62. PubMed ID: 6207511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntington's disease: changes in tachykinin content in postmortem brains.
    Arai H; Emson PC; Carrasco LH
    Ann Neurol; 1987 Nov; 22(5):587-94. PubMed ID: 2447825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in TRH receptors in temporal lobe of schizophrenics: a quantitative autoradiographic study.
    Lexow N; Joyce JN; Kim SJ; Phillips J; Casanova MF; Bird ED; Kleinman JE; Winokur A
    Synapse; 1994 Dec; 18(4):315-27. PubMed ID: 7886624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin in human brain: regional distribution and effects of neurological illness.
    Emson PC; Horsfield PM; Goedert M; Rossor MN; Hawkes CH
    Brain Res; 1985 Nov; 347(2):239-44. PubMed ID: 2933123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
    Ellison DW; Beal MF; Mazurek MF; Malloy JR; Bird ED; Martin JB
    Brain; 1987 Dec; 110 ( Pt 6)():1657-73. PubMed ID: 2892568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
    Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
    N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
    Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
    Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.